{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T19:31:05Z","timestamp":1723577465018},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ijantimicag.2005.08.022","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T12:17:48Z","timestamp":1131625068000},"page":"497-503","source":"Crossref","is-referenced-by-count":10,"title":["Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy"],"prefix":"10.1016","volume":"26","author":[{"given":"Eric","family":"Nuermberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Helke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.08.022_bib1","first-page":"556","article-title":"Premature deaths, monthly mortality and monthly physician contacts\u2014United States","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.08.022_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/324525","article-title":"Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999\u20132000","volume":"34","author":"Thornsberry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib4","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.47.6.1790-1797.2003","article-title":"Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000\u20132001 and 2001\u20132002 TRUST studies in the United States","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","article-title":"In vivo activities of amoxicillin and amoxicillin\u2013clavulanate against Streptococcus pneumoniae: application to breakpoint determinations","volume":"42","author":"Andes","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib7","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/AAC.46.9.2990-2995.2002","article-title":"Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model","volume":"46","author":"Xuan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/AAC.39.6.1253","article-title":"Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin","volume":"39","author":"Knudsen","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib9","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/AAC.36.12.2698","article-title":"In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia","volume":"36","author":"Azoulay-Dupuis","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib10","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.46.10.3185-3192.2002","article-title":"Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.38.9.1953","article-title":"In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model","volume":"38","author":"Moine","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1099\/00222615-45-5-319","article-title":"Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA\/J mice","volume":"45","author":"Takashima","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.47.2.739-746.2003","article-title":"Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model","volume":"47","author":"Hoffman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/IAI.66.3.912-922.1998","article-title":"Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice","volume":"66","author":"Bergeron","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/322021","article-title":"Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia","volume":"184","author":"Dallaire","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.40.6.1520","article-title":"Noncompromised penicillin-resistant pneumococcal pneumonia CBA\/J mouse model and comparative efficacies of antibiotics in this model","volume":"40","author":"Tateda","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/IAI.21.2.412-416.1978","article-title":"Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae","volume":"21","author":"Coil","year":"1978","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/339543","article-title":"A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults","volume":"34","author":"Ortiz-Ruiz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0149-2918(02)80078-9","article-title":"A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia","volume":"24","author":"Vetter","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib20","series-title":"Principles and practice of infectious diseases","first-page":"2128","article-title":"Streptococcus pneumoniae","author":"Musher","year":"2000"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000077804","article-title":"Differential efficacy of clarithromycin in lung versus thigh infection models","volume":"50","author":"Maglio","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkg375","article-title":"Properties and potential of ertapenem","volume":"52","author":"Livermore","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib24","unstructured":"Van Ogtrop ML, Andes D, Craig WA. In vivo antimicrobial activity of MK-0826, a new carbapenem, against various penicillin-resistant pneumococci. In: Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. F-48."},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib25","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/AAC.42.8.1996","article-title":"In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345)","volume":"42","author":"Gill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib26","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/AAC.45.7.2092-2097.2001","article-title":"Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae","volume":"45","author":"Mattoes","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. D","key":"10.1016\/j.ijantimicag.2005.08.022_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/31.suppl_D.149","article-title":"Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man","volume":"31","author":"Craig","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/IAI.60.1.111-116.1992","article-title":"Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae","volume":"60","author":"Briles","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2005.08.022_bib29","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/IAI.70.8.4226-4238.2002","article-title":"Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice","volume":"70","author":"Wang","year":"2002","journal-title":"Infect Immun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T19:47:33Z","timestamp":1586548053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0924857905002591"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.08.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}